Avantor® announces new scientific advisory board

Board will accelerate solutions for life sciences customers; includes experts in biologic manufacturing sciences and technology, chemistry and gene therapy radnor, pa. , sept. 21, 2023 /prnewswire/ -- avantor, inc. (nyse: avtr), a leading global provider of mission-critical products and services for customers in the life sciences and technology industries, today announced the creation of a new scientific advisory board (sab), which will provide strategic guidance and consult on the company's mid- to long-term research and development efforts to deliver solutions for the life sciences industry, including biotech and pharma customers.
AVTR Ratings Summary
AVTR Quant Ranking